Skip to content

Minimal Clinically Important Difference of the Box and Block Test in Parkinson

Examining the Clinical Significance of the Change in Manual Dexterity of Parkinson's Patients Receiving Conventional Physiotherapy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06490809
Enrollment
44
Registered
2024-07-08
Start date
2024-10-01
Completion date
2025-08-01
Last updated
2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson, Box and Block Test, Minimal Clinically Important Difference

Brief summary

The aim of this study is to examine the level of clinical change in gross manual skills of Parkinson's patients who receive conventional physiotherapy. For this purpose, the Box-Block Test will be used, and the amount of change that must occur in the patient's hand functions will be determined for the test to be considered clinically meaningful. Patients will continue their routine physical therapy sessions and the researchers will not interfere with this program. The treatment program will be created by the clinical specialist physician and physiotherapist. Upper extremity rehabilitation programs for Parkinson's patients generally consist of methods such as stretching, strengthening, reaching, coordination and recreational activities. Patients will receive physiotherapy for 30 sessions.

Interventions

OTHERPhysiotherapy

Parkinson's upper extremity rehabilitation generally consists of stretching, strengthening, coordination, recreational activities and skill activities. Exercises will be prescribed by the clinical specialist physician and physiotherapist.

Sponsors

Emre Şenocak
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Masking description

An independent Researcher will perform a statistical analysis.

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Being Hoehn & Yahr Stage between 1-3, * Individuals in the On phase, * Those who were not exposed to any physiotherapy intervention during the initial assessment

Exclusion criteria

* Mini-mental status assessment < 24 points; * Presence of severe dyskinesia, * Those who experience fluctuations in the on-off phase, * Those who have undergone stereotaxic brain surgery for Parkinson's, * Individuals with changes in dopamine dose within three months, * Presence of unstable cardiac and respiratory disease * Those with an orthopedic problem or a history of surgery affecting upper extremity performance.

Design outcomes

Primary

MeasureTime frameDescription
Box and Block TestBaseline of the studyThis test assesses gross manual dexterity. The number of wooden blocks moved during 60 seconds gives the total score. A high score indicates good dexterity.
Global Rating of Patient-Perceived Changes (GRP-PC)6 weeks (5 session days for 6 weeks)GRP-PC will used to assess patient-perceived hand dexterity changes after the routine intervention. The patient will first asked, Has your hand dexterity changed compared to when you did not receive interventions?. If the answer is no, the person will given a score of 0 (i.e. no change). In the case of positive response, the patient will asked, How much better or worse is your hand dexterity and the patient response will scored on the following 14-point Likert scale: +7 (very much better), +6 (much better), +5 (better), +4 (relatively better), +3 (somewhat better), +2 (a little better), +1 (very little better), -1 (very little worse), -2 (a little worse), -3 (somewhat worse), -4 (relatively worse), -5 (worse), -6 (much worse), and -7 (very much worse). This form will only be used to classify patients' satisfaction with treatment at the end of the study.

Secondary

MeasureTime frameDescription
Demographic Data FormBaseline of the studyThis form was created by researchers and it consist of personal informations such as gender, education, age, body mass index, dominant and affected extremity, disease duration, using medicine

Countries

Turkey (Türkiye)

Contacts

Primary ContactEmre Şenocak, PhD
emre.senocak@windowslive.com+90 553 569 56 92

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026